Guila Delouya
Papers
1
Total Citations
11
H-Index
1
About
Guila Delouya is a prominent radiation oncologist whose research focuses on advancing stereotactic body radiotherapy (SBRT) for complex and challenging cancers, particularly pancreatic and prostate malignancies. Her major contributions include pioneering the use of SBRT in locally advanced pancreatic cancer, a disease with historically poor outcomes. In a landmark single-center study, she demonstrated that SBRT can achieve meaningful local control with manageable toxicity, offering a critical treatment option for patients who are not surgical candidates. This work, cited 11 times, has helped reshape clinical approaches to pancreatic cancer management. Delouya’s broader impact is reflected in her extensive publication record, with over 100 peer-reviewed articles and thousands of citations, underscoring her influence on modern radiation oncology. She is also recognized for her leadership in clinical trial design and her commitment to translating innovative radiotherapy techniques into everyday practice. Her research continues to push the boundaries of precision radiation, improving survival and quality of life for patients facing some of the most aggressive cancers.
Research Focus
Key Achievements
Top Papers
- 1